Other Species / Isoforms
  TOB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y40-p
ERLLKKKyEGHWYPE
0 3
TOB1 (human) ERLLKKKyEGHWYPE Y40-p
TOB1 (mouse) ERLLKKKYEGHWYPE Y40
TOB1 (rat) ERLLKQKYEGHWYPE Y40
K73-ub
PVIEQASkESGLDID
0 1
TOB1 (human) PVIEQASkESGLDID K73-ub
TOB1 (mouse) PVIEQASKESGLDID K73
TOB1 (rat) PVIEQASKESGLDID K73
K110-ub
IGEKGPVkVLYVDDN
0 1
TOB1 (human) IGEKGPVkVLYVDDN K110-ub
TOB1 (mouse) IGEKGPVKVLYVDDS K110
TOB1 (rat) IGEKGPVKVLYVDDS K110
K126-ub
ENGCELDkEIKNSFN
0 1
TOB1 (human) ENGCELDkEIKNSFN K126-ub
TOB1 (mouse) ETGCELDKEIKNSFN K126
TOB1 (rat) ENGCELDKEIKNSFN K126
S152-p
PASSVSSsPsPPFGH
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
  • cell growth, inhibited
Kinase, in vitro:
  • ERK1 (human)
  • ERK2 (human)
  • JNK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Treatment
  • AG1296
  • EGF
  • estradiol
  • FGF1
  • PD98059
  • PDGF
  • serum
  • U0126
TOB1 (human) PASSVSSsPsPPFGH S152-p
TOB1 (mouse) PASSVSSSPSPPFGH S152
TOB1 (rat) PASSVSSSPSPPFGH S152
S154-p
SSVSSsPsPPFGHSA
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
  • cell growth, inhibited
Kinase, in vitro:
  • ERK1 (human)
  • ERK2 (human)
  • JNK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Treatment
  • AG1296
  • EGF
  • estradiol
  • FGF1
  • PD98059
  • PDGF
  • serum
  • U0126
TOB1 (human) SSVSSsPsPPFGHSA S154-p
TOB1 (mouse) SSVSSSPSPPFGHSA S154
TOB1 (rat) SSVSSSPSPPFGHSA S154
S164-p
FGHSAAVsPTFMPRS
Upstream
Downstream
4 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • cell cycle regulation
  • cell growth, altered
  • cell growth, inhibited
Kinase, in vitro:
  • ERK1 (human)
  • ERK2 (human)
  • JNK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
Regulatory protein:
  • TOB1 (human)
Treatment
  • AG1296
  • EGF
  • estradiol
  • FGF1
  • PD98059
  • PDGF
  • serum
  • U0126
TOB1 (human) FGHSAAVsPTFMPRS S164-p
TOB1 (mouse) FGHSAAVSPTFMPRS S164
TOB1 (rat) FGHSAAVSPTFMPRS S164
T172-p
PTFMPRStQPLTFTT
Upstream
Downstream
1 1
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • cell motility, induced
Treatment
  • staurosporine
TOB1 (human) PTFMPRStQPLTFTT T172-p
TOB1 (mouse) PTFMPRSTQPLTFTT T172
TOB1 (rat) PTFMPRSTQPLTFTT T172
T204-p
RSNKVARtsPINLGL
0 5
TOB1 (human) RSNKVARtsPINLGL T204-p
TOB1 (mouse) RSSKVARTsPINLGL T204
TOB1 (rat) RSSKVARTSPISLGL T204
S205-p
SNKVARtsPINLGLN
Upstream
0 6
Treatment
  • ischemia
TOB1 (human) SNKVARtsPINLGLN S205-p
TOB1 (mouse) SSKVARTsPINLGLT S205-p
TOB1 (rat) SSKVARTSPISLGLN S205
S268-p
QQKTSALsPNAKEFI
0 1
TOB1 (human) QQKTSALsPNAKEFI S268-p
TOB1 (mouse) QQQTSALSPNAKEFI S285
TOB1 (rat) QQQTSALSPNAKEFI S288
S320-p
YGGLNEKsFVDGLNF
Upstream
Downstream
1 1
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • cell motility, induced
Treatment
  • staurosporine
TOB1 (human) YGGLNEKsFVDGLNF S320-p
TOB1 (mouse) YGGLNEKSFVDGLNF S337
TOB1 (rat) YGGLNEKSFVDGLNF S340